Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.79 USD | -7.86% | -24.65% | -42.61% |
23/05 | Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM | |
22/05 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.61% | 86Cr | |
+10.79% | 12TCr | |
+11.65% | 11TCr | |
-6.20% | 2.39TCr | |
-3.23% | 2.16TCr | |
-10.97% | 1.9TCr | |
-13.41% | 1.63TCr | |
-40.50% | 1.7TCr | |
+6.64% | 1.41TCr | |
+31.84% | 1.2TCr |
- Stock Market
- Equities
- SRRK Stock
- News Scholar Rock Holding Corporation
- Scholar Rock Shares Fall on Wider-Than-Expected Q1 Loss